Proteros tasked with delivering protein-ligand-structures of active fragments from Bayer HealthCare’s drug discovery programs.
Proteros biostructures achieved the first milestone of its research collaboration with Bayer HealthCare in the field of fragment-based protein crystallography.
Under the terms of the agreement, Proteros will also receive a copy of the jointly selected fragment library for its own use.
In the partnership, which started in June 2006, Proteros applies its target know-how, Free Mounting System, and Picodropper™ technologies to deliver protein-ligand-structures of active fragments from Bayer HealthCare’s drug discovery programs.